Bacteria: Gram-positive

Clostridium perfringens, C. septicum and C. novyi

Clostridium perfringens; Clostridium septicum; Clostridium novyi

General medical information for education only, not medical advice. Treatment considerations summarize published guidance at drug-class level; therapy is chosen by the treating clinician using susceptibility results, local resistance patterns and current guidelines.

Overview

Spore-forming anaerobic Gram-positive rods from soil and the gut that produce tissue-damaging toxins.

Infections

Gas gangrene (clostridial myonecrosis) and necrotizing wound infection; C. perfringens food poisoning; C. septicum bacteremia linked to colon cancer; C. novyi wound infection, including in people who inject drugs.

Signs and symptoms

Severe pain, swelling and crepitus around a wound, with systemic toxicity; with food poisoning, cramps and watery diarrhea.

Antibiotic and antimicrobial resistance

Generally penicillin-susceptible; clindamycin resistance occurs.

Treatment considerations

Gas gangrene is a surgical emergency: debridement with penicillin plus clindamycin. Food poisoning is self-limited. C. septicum bacteremia should prompt colon evaluation.

Green barrel-shaped Clostridium perfringens bacteria, 3D illustration
Clostridium perfringens, 3D illustration based on electron micrographs. CDC (J. Oosthuizen); CC0. Image source
Gram-positive spore-forming rods, schematic
Gram-positive spore-forming rods. Schematic, not to scale; InnovexLab.

Sources

  1. CDC. Clostridium perfringens food poisoning.
  2. IDSA. Skin and Soft Tissue Infections guideline.

Sources accessed November 2026. Links open external sites that InnovexLab does not control.

Medical disclaimer

This page is general educational information summarized from published public-health and professional-society guidance. It is not medical advice, a diagnosis or a treatment recommendation, and reading it does not create a clinician–patient relationship with InnovexLab. Decisions about testing, diagnosis and treatment belong to the treating clinician, using the patient’s history and examination, laboratory and susceptibility results, local resistance patterns and current guidelines. Guidance changes over time; consult the original sources for the latest version. InnovexLab provides this information as is and does not warrant that it is complete or current.

Patients with questions about their health should contact their own healthcare provider. In an emergency, call 911.

Sources, image credits and editorial policy

Discuss a testing program with InnovexLab

Review the panel that fits your patients, its specimen requirements, and how results and billing work.